An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor

SORL1 encodes a 250-kDa protein named sorLA, a functional sorting receptor for the amyloid precursor protein (APP). Several single nucleotide polymorphisms of the gene SORL1, encoding sorLA, are genetically associated with Alzheimer's disease (AD). In the existing literature, SORL1 is insufficiently described at the transcriptional level, and there is very limited amount of functional data defining different transcripts. We have characterized a SORL1 transcript containing a novel exon 30B. The transcript is expressed in most brain regions with highest expression in the temporal lobe and hippocampus. Exon 30B is spliced to exon 31, leading to a mature transcript that encodes an 829 amino acid sorLA receptor. This receptor variant lacks the binding site for APP and is unlikely to function in APP sorting. This transcript is expressed in equal amounts in the cerebellum from AD and non-AD individuals. Our data describe a transcript that encodes a truncated sorLA receptor, suggesting novel neuronal functions for sorLA and that alternative transcription provides a mechanism for SORL1 activity regulation.

[1]  Julia E. Seaman,et al.  The DegraBase: A Database of Proteolysis in Healthy and Apoptotic Human Cells* , 2012, Molecular & Cellular Proteomics.

[2]  R. Hammer,et al.  Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning , 2014, Science Signaling.

[3]  P. Madsen,et al.  Characterization of sorCS1, an Alternatively Spliced Receptor with Completely Different Cytoplasmic Domains That Mediate Different Trafficking in Cells* , 2003, The Journal of Biological Chemistry.

[4]  B Croisile,et al.  High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease , 2012, Molecular Psychiatry.

[5]  T. Willnow,et al.  Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease , 2016, Acta Neuropathologica.

[6]  S. Leurgans,et al.  Neuronal LR11/sorLA expression is reduced in mild cognitive impairment , 2007, Annals of neurology.

[7]  P. Ambros,et al.  Identification of a Novel Exon in Apolipoprotein E Receptor 2 Leading to Alternatively Spliced mRNAs Found in Cells of the Vascular Wall but Not in Neuronal Tissue* , 2001, The Journal of Biological Chemistry.

[8]  J. Cui,et al.  Reduction of sortilin-1 in Alzheimer hippocampus and in cytokine-stressed human brain cells , 2007, Neuroreport.

[9]  Cornelia M. Wilson,et al.  The implications of sortilin/vps10p domain receptors in neurological and human diseases. , 2014, CNS & neurological disorders drug targets.

[10]  A. Levey,et al.  The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments , 2006, The Journal of Neuroscience.

[11]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[12]  K. Welsh-Bohmer,et al.  The Alzheimer's associated 5′ region of the SORL1 gene cis regulates SORL1 transcripts expression , 2012, Neurobiology of Aging.

[13]  Tamara Aid,et al.  Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters☆ , 2007, Genomics.

[14]  N. Tommerup,et al.  Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein* , 1996, The Journal of Biological Chemistry.

[15]  K. Sleegers,et al.  Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene , 2017, Acta Neuropathologica Communications.

[16]  S. Thirup,et al.  Hidden Twins: SorCS Neuroreceptors Form Stable Dimers. , 2017, Journal of molecular biology.

[17]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Abdullah M. Khamis,et al.  Regional differences in gene expression and promoter usage in aged human brains , 2013, Neurobiology of Aging.

[19]  P. S. St George-Hyslop,et al.  Vps10 Family Proteins and the Retromer Complex in Aging-Related Neurodegeneration and Diabetes , 2012, The Journal of Neuroscience.

[20]  M. Pericak-Vance,et al.  Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP) , 2013, Translational Psychiatry.

[21]  K. Nakai,et al.  Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. , 2005, Genome research.

[22]  Ishita Guha Thakurta,et al.  Associations of sorLA/SORL1 with Alzheimer's disease , 2015 .

[23]  R. Cancedda,et al.  An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples , 2012, Disease Models & Mechanisms.

[24]  Xi Chen,et al.  Systematic analysis of alternative promoters correlated with alternative splicing in human genes. , 2009, Genomics.

[25]  P. Madsen,et al.  Sortilin and SorLA Display Distinct Roles in Processing and Trafficking of Amyloid Precursor Protein , 2013, The Journal of Neuroscience.

[26]  Vanessa Schmidt,et al.  Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. , 2006, Biochemistry.

[27]  W. Schneider,et al.  A secreted soluble form of ApoE receptor 2 acts as a dominant‐negative receptor and inhibits Reelin signaling , 2002, The EMBO journal.

[28]  L. Petrucelli,et al.  Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor , 2012, Proceedings of the National Academy of Sciences.

[29]  M. Frotscher,et al.  Modulation of Synaptic Plasticity and Memory by Reelin Involves Differential Splicing of the Lipoprotein Receptor Apoer2 , 2005, Neuron.

[30]  A. Levey,et al.  Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[31]  W. Schneider,et al.  Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[32]  W. Hampe,et al.  The genes for the human VPS10 domain-containing receptors are large and contain many small exons , 2001, Human Genetics.

[33]  M. Schachner,et al.  Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration , 2006, Nature Neuroscience.

[34]  H. Schaller,et al.  Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. , 2000, Journal of cell science.

[35]  J. Nyengaard,et al.  Sorting by the Cytoplasmic Domain of the Amyloid Precursor Protein Binding Receptor SorLA , 2007, Molecular and Cellular Biology.

[36]  A. Smit,et al.  The sorLA cytoplasmic domain interacts with GGA1 and ‐2 and defines minimum requirements for GGA binding , 2002, FEBS letters.

[37]  T. Willnow,et al.  Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease , 2013, Journal of Cell Science.

[38]  A. Levey,et al.  GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production , 2012, Molecular biology of the cell.

[39]  Vanessa Schmidt,et al.  Sortilin-related Receptor with A-type Repeats (SORLA) Affects the Amyloid Precursor Protein-dependent Stimulation of ERK Signaling and Adult Neurogenesis* , 2008, Journal of Biological Chemistry.

[40]  A. Sporbert,et al.  SorLA/LR11 Regulates Processing of Amyloid Precursor Protein via Interaction with Adaptors GGA and PACS-1* , 2007, Journal of Biological Chemistry.

[41]  T. Hibi,et al.  Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin , 2009, Neuroscience Research.

[42]  Giuliano Binetti,et al.  A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease , 2016, Acta Neuropathologica.

[43]  W. Schneider,et al.  Alternative Splicing in the Ligand Binding Domain of Mouse ApoE Receptor-2 Produces Receptor Variants Binding Reelin but Not α2-Macroglobulin* , 2001, The Journal of Biological Chemistry.

[44]  M. Saarma,et al.  Multiple promoters direct tissue-specific expression of the rat BDNF gene , 1993, Neuron.

[45]  W. M. van der Flier,et al.  Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy , 2017, European Journal of Human Genetics.

[46]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[47]  A. Bird,et al.  CpG islands and the regulation of transcription. , 2011, Genes & development.

[48]  Hyunsoo Kim,et al.  Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development. , 2011, Genome research.

[49]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[50]  H. Schaller,et al.  Unique expression pattern of a novel mosaic receptor in the developing cerebral cortex , 1998, Mechanisms of Development.

[51]  Maido Remm,et al.  Enhancements and modifications of primer design program Primer3 , 2007, Bioinform..

[52]  B. Faircloth,et al.  Primer3—new capabilities and interfaces , 2012, Nucleic acids research.

[53]  J. Bonifacino,et al.  Polarized trafficking of the sorting receptor SorLA in neurons and MDCK cells , 2016, The FEBS journal.

[54]  Dietmar Kuhl,et al.  Different Motifs Regulate Trafficking of SorCS1 Isoforms , 2008, Traffic.

[55]  F. Schmitt,et al.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain , 2009, Molecular Neurodegeneration.

[56]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[57]  J. Kobayashi,et al.  Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells. , 2000, Biochemical and Biophysical Research Communications - BBRC.

[58]  J. Nyengaard,et al.  SorLA controls neurotrophic activity by sorting of GDNF and its receptors GFRα1 and RET. , 2013, Cell reports.

[59]  J. Nyengaard,et al.  Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing , 2012, The Journal of Neuroscience.

[60]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[61]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[62]  Lin Lu,et al.  Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine , 2006, Brain Research.

[63]  A. Heck,et al.  Low pH-induced conformational change and dimerization of sortilin triggers endocytosed ligand release , 2017, Nature Communications.

[64]  T. Willnow,et al.  VPS10P-domain receptors — regulators of neuronal viability and function , 2008, Nature Reviews Neuroscience.

[65]  G. Larson,et al.  SorLA Complement-type Repeat Domains Protect the Amyloid Precursor Protein against Processing* , 2014, The Journal of Biological Chemistry.

[66]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.